During the past decade, University of Pittsburgh Medical Center conducted 609 clinical trials. In the 10-year time frame, 609 clinical trials started and 285 clinical trials were completed, i.e. on average, 46.8% percent of trials that started reached the finish line to date. In the past 5 years, 291 clinical trials started and 157 clinical trials were completed. i.e. 54% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Pittsburgh Medical Center" #1 sponsor was "University of Pittsburgh" with 199 trials, followed by "Abbott Medical Devices" with 26 trials sponsored, "Janssen Research & Development, LLC" with 20 trials sponsored, "Boston Scientific Corporation" with 19 trials sponsored and "Bristol-Myers Squibb" with 19 trials sponsored. Other sponsors include 809 different institutions and companies that sponsored additional 479 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pittsburgh Medical Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 34 trials as a collaborator, "University of Pittsburgh" with 31 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 21 trials as a collaborator, "University of Pittsburgh Medical Center" with 20 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 17 trials as a collaborator. Other collaborators include 710 different institutions and companies that were collaborators in the rest 432 trials.

According to Clinical.Site data, the most researched conditions in "University of Pittsburgh Medical Center" are "Depression" (21 trials), "Pulmonary Arterial Hypertension" (19 trials), "Pulmonary Hypertension" (19 trials), "Coronary Artery Disease" (17 trials) and "Melanoma" (16 trials). Many other conditions were trialed in "University of Pittsburgh Medical Center" in a lesser frequency.

Most popular intervention types in "University of Pittsburgh Medical Center" are "Drug" (538 trials), "Device" (225 trials), "Other" (135 trials), "Biological" (84 trials) and "Behavioral" (73 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (121 trials), "Nivolumab" (14 trials), "Bevacizumab" (12 trials), "placebo" (12 trials) and "Cyclophosphamide" (8 trials). Other intervention names were less common.

The vast majority of trials in "University of Pittsburgh Medical Center" are 1030 trials for "All" genders, 52 trials for "Female" genders and 15 trials for "Male" genders.

Currently, there are 331 active trials in "University of Pittsburgh Medical Center". 6 are not yet recruiting, 183 are recruiting, 135 are Active, not recruiting, and 7 are Enrolling by invitation. In total, there were 587 completed trials in University of Pittsburgh Medical Center, undefined suspended trials, and 127 terminated clinical trials to date.

Out of the total trials that were conducted in University of Pittsburgh Medical Center, 126 "Phase 1" clinical trials were conducted, 253 "Phase 2" clinical trials and 222 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 58 trials, and there were also 263 trials that are defined as “Not Applicable".

University of Pittsburgh Medical Center has several departments that took part in Clinical trials: "UPMC Cancer Centers - Arnold Palmer Pavilion" - 116 trials, "Cherry Tree Cancer Center" - 100 trials, "UPMC Cancer Center at UPMC McKeesport" - 91 trials, "UPMC Cancer Center at UPMC Northwest" - 90 trials, "UPMC-Johnstown/John P. Murtha Regional Cancer Center" - 89 trials, "UPMC-Saint Clair Hospital Cancer Center" - 87 trials, "UPMC-Coraopolis/Heritage Valley Radiation Oncology" - 76 trials, "UPMC Washington Hospital Radiation Oncology" - 74 trials, "UPMC Hillman Cancer Center Erie" - 74 trials, "UPMC Hillman Cancer Center" - 532 trials, "UPMC Uniontown Hospital Radiation Oncology" - 67 trials, "Pinnacle Health Cardiovascular Institute" - 43 trials, "UPMC Jefferson Regional Radiation Oncology" - 43 trials, "UPMC Cancer Center - Monroeville" - 40 trials, "Trinity's Tony Teramana Cancer Center" - 37 trials, "University of Pittsburgh CRS" - 33 trials, "UPMC Cancer Center-Washington" - 33 trials, "Carlisle Regional Cancer Center" - 32 trials, "UPMC Cancer Center at UPMC Horizon" - 30 trials, "UPMC Cancer Center-Uniontown" - 28 trials, "UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion" - 28 trials, "UPMC Center For Liver Diseases" - 23 trials, "University of Pittsburgh Cardiovascular Institute" - 22 trials, "IRMC Cancer Center" - 20 trials, "UPMC Cancer Center at Magee-Womens Hospital" - 20 trials